IN8BIO, INC. (INAB) — Institutional Holders, Q2 2026

21 institutional investment managers reported a INAB position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $6.7M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.

INAB in Q2 2026: what funds did

Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.

New positions

5

Added to

5

Trimmed

3

Sold out

1

Biggest buyers

  1. Stonepine Capital ManagementAdded · +961,150 sh+$1.4M
  2. VANGUARD CAPITAL MANAGEMENTNew · +88,865 sh+$125.3K
  3. CITADEL ADVISORSNew · +63,055 sh+$88.9K
  4. VANGUARD FIDUCIARYNew · +43,570 sh+$61.4K
  5. OPPENHEIMERAdded · +39,009 sh+$55.0K

Biggest sellers

  1. BIOS Capital ManagementTrimmed · -86,848 sh-$122.5K
  2. GEODE CAPITAL MANAGEMENTTrimmed · -13,689 sh-$19.3K
  3. XTX Topco LtdSold out · -12,433 sh-$17.5K
  4. UBS Group AGTrimmed · -479 sh-$675.00

INAB 13F holders ranked 1–21 of 21

Institutional investors reporting a position in IN8BIO, INC. on SEC Form 13F-HR for Q2 2026, ranked by reported value.
InstitutionValueQoQ
Stonepine Capital Management#1 · 1,624,562 sh$2.3M+144.9%
Alyeska Investment Group, L.P.#2 · 944,319 sh$1.3M0.0%
FRANKLIN RESOURCES#3 · 914,531 sh$1.3M0.0%
683 Capital Management#4 · 724,637 sh$1.0M0.0%
VANGUARD CAPITAL MANAGEMENT#5 · 88,865 sh$126.5KNew
BIOS Capital Management#6 · 80,957 sh$114.1K-51.8%
GEODE CAPITAL MANAGEMENT#7 · 72,550 sh$102.3K-15.9%
CITADEL ADVISORS#8 · 63,055 sh$88.9KNew
OPPENHEIMER#9 · 63,042 sh$88.9K+162.3%
VANGUARD FIDUCIARY#10 · 43,570 sh$62.0KNew
CAPTRUST FINANCIAL ADVISORS#11 · 33,295 sh$46.9K0.0%
Texas Capital Bank Wealth Management Services#12 · 24,406 sh$34.4K+2.8%
NORTHERN#13 · 21,734 sh$30.6K+6.3%
RENAISSANCE TECHNOLOGIES#14 · 12,100 sh$17.1KNew
Tower Research Capital (TRC)#15 · 3,738 sh$5.3K+195.5%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT#16 · 2,785 sh$3.9K0.0%
JONES FINANCIAL COMPANIES LLLP#17 · 768 sh$1.0K0.0%
BlackRock#18 · 84 sh$118.000.0%
Rockefeller Capital Management L.P.#19 · 83 sh$117.000.0%
BARCLAYS PLC#20 · 28 sh$39.00New
UBS Group AG#21 · 1 sh$1.00-99.8%

Funds that sold out of INAB in Q2 2026 (1)

Held INAB at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.

Institutions that held INAB in Q1 2026 and reported no position in Q2 2026.
InstitutionValue in Q1 2026
XTX Topco Ltd12,433 sh$18.4K

Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.